Clinical & Experimental Immunology

Heat shock proteins and innate immunity
pp. 1-3(3)
Author: Gaston J.S.H.

Transgenic models of autoimmune disease
pp. 4-11(8)
Authors: Boyton R.J.; Altmann D.M.

B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity
pp. 12-19(8)
Authors: Bagenstose L.M.; Class R.; Salgame P.; Monestier M.

IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer
pp. 20-26(7)
Authors: Riemensberger J.; Böhle A.; Brandau S.

Trypanosoma cruzi mitochondrial malate dehydrogenase triggers polyclonal B-cell activation
pp. 27-36(10)
Authors: Montes C.L.; Zuñiga E.I.; Vazquez J.; Arce C.; Gruppi A.

Extra-articular cartilage affected in collagen-induced, but not pristane-induced, arthritis models
pp. 37-42(6)
Authors: Hansson A-S.; Lu S.; Holmdahl R.

Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients
pp. 43-52(10)
Authors: Chau L.A.; Rohekar S.; Wang J.-J.; Lian D.; Chakrabarti S.; Zhang L.; Zhong R.; Madrenas J.

IL-1ra and IL-1 production in human oral mucosal epithelial cells in culture: differential modulation by TGF-1 and IL-4
pp. 53-59(7)
Authors: Perrier S.; Kherratia B.; Deschaumes C.; Ughetto S.; Kemeny J.-L.; Baudet-Pommel M.; Sauvezie B.

Differential expression of 1 and 2 integrins and L-selectin on CD4⁺ and CD8⁺ T lymphocytes in human blood: comparative analysis between isolated cells, whole blood samples and cryopreserved preparations
pp. 60-65(6)
Authors: Cavers M.; Afzali Khoshkbijari B.; Macey M.; Mccarthy D.A.; Irshad S.; Brown K.A.

Regulation of primary HIV-1 isolate replication in dendritic cells
pp. 66-71(6)
Authors: MacDougall T.H.J.; Shattock R.J.; Madsen C.; Chain B.M.; Katz D.R.

Self-heat shock protein 60 induces tumour necrosis factor- in monocyte-derived macrophage: possible role in chronic inflammatory periodontal disease
pp. 72-77(6)
Authors: Ueki K.; Tabeta K.; Yoshie H.; Yamazaki K.

The effect of IL-18 on IL-12-induced CD30 expression and IL-4 and IFN- production by allergen and PPD specific T cells
pp. 78-84(7)
Authors: Tarkowski M.; Chrul S.; Bodalski J.

Proliferation of T-cell subsets that contact tumour cells in colorectal cancer
pp. 85-91(8)
Authors: Golby S.J.C.; Chinyama C.; Spencer J.

Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity
pp. 92-98(7)
Authors: Akamizu T.; Ozaki S.; Hiratani H.; Uesugi H.; Sobajima J.; Hataya Y.; Kanamoto N.; Saijo M.; Hattori Y.; Moriyama K.; Ohmori K.; Nakao K.

The prevalence of autoantibodies in an elderly sub-Saharan African population
pp. 99-106(8)
Authors: Njemini R.; Meyers I.; Demanet C.; Smitz J.; Sosso M.; Mets T.

Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?
pp. 107-114(8)
Authors: Sandmand M.; Bruunsgaard H.; Kemp K.; Andersen-Ranberg K.; Pedersen A.N.; Skinhøj P.

A hampered chemoattractant-induced cytoskeletal rearrangement in granulocytes of patients with unexplained severe chronic and relapsing infections of the upper and lower airways. In vitro restoration by G-CSF exposure
pp. 115-122(8)
Authors: Kalkman P.M.J.; Fokkens W.J.; de Wit H.J.; van de Merwe J.P.; Hooijkaas H.; van Haarst J.M.W.; Hoogsteden H.C.; Drexhage H.A.

Increased soluble p55 and p75 tumour necrosis factor- receptors in patients with hepatitis C-associated mixed cryoglobulinaemia
pp. 123-130(8)
Authors: Kaplanski G.; Marin V.; Maisonobe T.; Sbai A.; Farnarier C.; Ghillani P.; Thirion X.; Durand J.M.; Harlé J.R.; Bongrand P.; Piette J.C.; Cacoub P.

Complement C4 monitoring in the follow-up of chronic hepatitis C treatment
pp. 131-136(6)
Authors: Dumestre-Perard C.; Ponard D.; Drouet C.; Leroy V.; Zarski J-P.; Dutertre N.; Colomb M.G.

The CD28/HLA-DR expressions on CD4⁺T but not CD8⁺T cells are significant predictors for progression to AIDS
pp. 137-144(8)
Authors: Choi B-S.; Park Y-K.; Lee J-S.

Characterization of the phenotypic and lymphokine profile associated with strong CD8⁺ anti-HIV-1 suppressor activity (CASA)
pp. 145-150(7)
Authors: Wilkinson J.; Zaunders J.J.; Carr A.; Guillemin G.; Cooper D.A.

Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria
pp. 151-157(7)
Authors: Kemp K.; Akanmori B.D.; Adabayeri V.; Goka B.Q.; Kurtzhals J.A.L.; Behr C.; Hviid L.

High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals
pp. 158-164(7)
Authors: Consigny P.H.; Cauquelin B.; Agnamey P.; Comby E.; Brasseur P.; Ballet J.J.; Roussilhon C.

Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects
pp. 165-171(7)
Authors: Martínez-Cáceres E.M.; Barrau M.A.; Brieva L.; Espejo C.; Barberà N.; Montalban X.

Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders
pp. 172-175(4)
Authors: Muratori P.; Muratori L.; Cassani F.; Terlizzi P.; Lenzi M.; Rodrigo L.; Bianchi F.B.

CD3⁺CD56⁺ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis
pp. 176-182(7)
Authors: Koreck A.; Surányi A.; Szöny B.J.; Farkas Á.; Bata-Csörgö Z.; Kemény L.; Dobozy A.

Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy
pp. 183-189(7)
Authors: Ankersmit H.J.; Moser B.; Roedler S.; Teufel I.; Zuckermann A.; Roth G.; Lietz K.; Back C.; Gerlitz S.; Wolner E.; Boltz-Nitulescu G.